Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

EMAPALUMAB for Still's disease: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 14 adverse event reports in the FDA FAERS database where EMAPALUMAB was used for Still's disease.

Most Reported Side Effects for EMAPALUMAB

Side Effect Reports % Deaths Hosp.
Off label use 67 38.7% 22 45
Condition aggravated 37 21.4% 6 24
Drug ineffective 37 21.4% 14 24
Haemophagocytic lymphohistiocytosis 33 19.1% 8 21
Multiple organ dysfunction syndrome 22 12.7% 18 18
Staphylococcal bacteraemia 17 9.8% 1 1
Adrenal insufficiency 14 8.1% 0 13
Drug reaction with eosinophilia and systemic symptoms 14 8.1% 0 13
Respiratory failure 14 8.1% 4 12
Pyrexia 12 6.9% 0 7
Disseminated mucormycosis 11 6.4% 11 11
Disseminated intravascular coagulation 10 5.8% 10 10
Acute kidney injury 9 5.2% 0 9
Clostridium difficile infection 9 5.2% 0 9
Cytomegalovirus infection 9 5.2% 2 7

Other Indications for EMAPALUMAB

Haemophagocytic lymphohistiocytosis (119) Familial haemophagocytic lymphohistiocytosis (21) Product used for unknown indication (10) Epstein-barr virus infection (7) Prophylaxis (7)

Other Drugs Used for Still's disease

CANAKINUMAB (1,847) ANAKINRA (1,563) TOCILIZUMAB (1,418) METHOTREXATE (703) CYCLOSPORINE (387) PREDNISOLONE (384) PREDNISONE (328) METHYLPREDNISOLONE (275) ETANERCEPT (202) INFLIXIMAB (181)

Related Pages

EMAPALUMAB Full Profile All Still's disease Drugs EMAPALUMAB Demographics EMAPALUMAB Timeline